Fosgemcitabine Palabenamide
Fosgemcitabine Palabenamide Uses, Dosage, Side Effects, Food Interaction and all others data.
Fosgemcitabine Palabenamide is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).
| Trade Name | Fosgemcitabine Palabenamide |
| Generic | NUC-1031 |
| NUC-1031 Other Names | ACELARIN, Fosgemcitabine palabenamide, p(rs)- |
| Type | |
| Formula | C25H27F2N4O8P |
| Weight | Average: 580.482 Monoisotopic: 580.153457169 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Fosgemcitabine Palabenamide
